- £472.03m
- £1.08bn
- €1.89bn
- 33
- 84
- 58
- 62
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,781 | 1,775 | 1,694 | 1,869 | 1,892 |
Cost of Revenue | |||||
Gross Profit | 310 | 308 | 285 | 357 | 362 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,842 | 1,804 | 1,658 | 1,745 | 1,771 |
Operating Profit | -61.6 | -28.1 | 36.1 | 124 | 121 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -89 | -59.4 | 10.9 | 95.7 | 93.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -76.6 | -60.5 | 5.5 | 75.4 | 66.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -92.8 | -77.9 | 5.6 | 74.5 | 62.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -92.8 | -77.9 | 5.6 | 74.5 | 62.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.63 | 0.98 | 0.83 | 1.24 | 0.979 |
Dividends per Share |